Co-Diagnostics Inc.

CODX | NASDAQ

Price Alert Chart Builder DCF Calculator

$1.01

+$0.06 (+6.80%)

At close: Sep 21, 2026, 4:00 PM ET

$1.04

+$0.03 (+2.97%)

Pre-market: Sep 22, 2026, 5:40 AM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

+6.80%

(1D)

Rating

Updated: Aug 29, 2026

Fundamentals Weak

Market Sentiment Neutral

Moat None

Full Analysis

Key Statistics

Market Data

Market Cap $1.13M

1D Range

0.98 1.04

52W Range

0.91 46.50

Valuation (TTM)

PE -0.04

PB 0.09

EV/EBITDA 0.02

Valuation (NTM)

Forward PE N/A

Forward PEG 0.00

Price Target $180

Cash Flow

FCF Yield -2436.6%

SBC Adj. FCF Yield -2545.3%

SBC Impact -4.5%

Margins

Gross Margin 8.1%

Operating Margin -4170.1%

FCF Margin -3808.0%

Growth (CAGR)

Revenue 3Y | 5Y -53.8% | -62.4%

Dil EPS 3Y | 5Y 16.0% | -47.3%

FCF 3Y | 5Y -3.5% | -79.0%

Returns

ROA -283.6%

ROE -211.0%

ROIC -200.4%

Financial Health

Net Cash

$1.85M

Current Ratio 1.81

Interest Coverage 0.00

Dividends

Div Yield N/A

Payout Ratio N/A

FCF Payout Ratio N/A

All Key Statistics

Loading financial charts...

Profile

Co-Diagnostics, Inc. operates as a molecular diagnostics company that develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nuclei...

Sector Healthcare

Industry Biotechnology

Employees 115

IPO Date Jul 11, 2017

Website co-dx.com

Fiscal Year January - December

Full Company Profile

Latest News

No news articles available yet.

Earnings

Next Earnings

Nov 16, 2026

EPS Est

Pro

Rev Est

Pro

Earnings Details ➞

Analyst Summary

# of Analysts

Consensus

Hold

Price Target

$180

Upside

+17721.78%

Buy (1)

Hold (1)

Sell (0)

Analyst Details ➞